American Gastroenterological Association technical review on the management of Barrett's esophagus.

The aim of evidence-based medicine is to improve the quality of health care by integrating the best research evidence with clinical expertise and patient values. Evidence-based clinical guidelines are sets of recommendations intended to assist health care providers and patients in selecting the best management for common clinical situations while accounting for patient-specific circumstances. In addition to providing optimal, patient-centered care and improved outcomes, guidelines can reduce practice variability, identify gaps in evidence, enhance efficiency of resource use, and facilitate development of outcome and performance measures.

[1]  A. Bhattacharyya,et al.  Medication usage and the risk of neoplasia in patients with Barrett's esophagus. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  P. Devitt,et al.  Prospective Randomized Trial of Argon Plasma Coagulation Ablation Versus Endoscopic Surveillance of Barrett’s Esophagus in Patients Treated with Antisecretory Medication , 2009, Digestive Diseases and Sciences.

[3]  T. Rice,et al.  An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. , 2009, Gastrointestinal endoscopy.

[4]  Hiroaki Ikematsu,et al.  Narrow‐band Imaging , 2009 .

[5]  A. Neugut,et al.  Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  Patricia L. Blount,et al.  Intestinal Differentiation in Metaplastic, Nongoblet Columnar Epithelium in the Esophagus , 2009, The American journal of surgical pathology.

[7]  Seth D. Crockett,et al.  Health-related quality of life in patients with Barrett's esophagus: a systematic review. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  A. Chak,et al.  Receipt of Previous Diagnoses and Endoscopy and Outcome From Esophageal Adenocarcinoma: A Population-Based Study With Temporal Trends , 2009, The American Journal of Gastroenterology.

[9]  N. Shaheen,et al.  A cost-utility analysis of ablative therapy for Barrett's esophagus. , 2009, Gastroenterology.

[10]  Hiroshi Mashimo,et al.  Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.

[11]  A. Bhattacharyya,et al.  A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. , 2009, Cancer research.

[12]  Ananya Das,et al.  Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. , 2009, Gastrointestinal endoscopy.

[13]  R. Hawes,et al.  Detection of Metaplasia (IM) and Neoplasia in Patients with Barrett's Esophagus (BE) Using High-Definition White Light Endoscopy (HD-WLE) Versus Narrow Band Imaging (NBI): A Prospective, Multi-Center, Randomized, Crossover Trial , 2009 .

[14]  A. Charlett,et al.  Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[15]  R. Parthasarathi,et al.  NOTES: Transvaginal Endoscopic Cholecystectomy in Humans—Preliminary Report of a Case Series , 2009, The American Journal of Gastroenterology.

[16]  J. Hornick,et al.  Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. , 2009, Gastrointestinal endoscopy.

[17]  G. Block,et al.  Cigarette smoking and the risk of Barrett’s esophagus , 2009, Cancer Causes & Control.

[18]  R. Goyal,et al.  Metaplastic Esophageal Columnar Epithelium Without Goblet Cells Shows DNA Content Abnormalities Similar to Goblet Cell–Containing Epithelium , 2009, The American Journal of Gastroenterology.

[19]  G. Block,et al.  Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. , 2009, Gastroenterology.

[20]  T. Vaughan,et al.  Vegetable and fruit intakes and risk of Barrett's esophagus in men and women. , 2009, The American journal of clinical nutrition.

[21]  H. Comber,et al.  The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. , 2009, Gastroenterology.

[22]  Jeffrey S. Morris,et al.  Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis. , 2009, The Annals of thoracic surgery.

[23]  A. Rastogi,et al.  Esophageal Adenocarcinoma in Barrett's Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review , 2009, The American Journal of Gastroenterology.

[24]  Ananya Das,et al.  Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia , 2009, The American Journal of Gastroenterology.

[25]  F. Torelli,et al.  Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors. , 2009, World journal of gastroenterology.

[26]  C. Abnet,et al.  Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis , 2009, British Journal of Cancer.

[27]  Hirokazu Takahashi,et al.  Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men , 2008, BMC gastroenterology.

[28]  M. Zenker.  Argon plasma coagulation , 2008, GMS Krankenhaushygiene interdisziplinar.

[29]  A. Sonnenberg,et al.  Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. , 2008, Gastrointestinal endoscopy.

[30]  Kenneth J. Chang,et al.  Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. , 2008, Gastrointestinal endoscopy.

[31]  W. Hop,et al.  Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus. , 2008, American journal of clinical pathology.

[32]  G. Block,et al.  Race, ethnicity, sex and temporal differences in Barrett’s oesophagus diagnosis: a large community-based study, 1994–2006 , 2008, Gut.

[33]  A. Leong,et al.  p16, Cyclin D1, Ki-67, and AMACR as Markers for Dysplasia in Barrett Esophagus , 2008, Applied immunohistochemistry & molecular morphology : AIMM.

[34]  T. Djärv,et al.  Long‐term health‐related quality of life following surgery for oesophageal cancer , 2008, The British journal of surgery.

[35]  M. Bronner,et al.  Poor Interobserver Agreement in the Distinction of High-Grade Dysplasia and Adenocarcinoma in Pretreatment Barrett's Esophagus Biopsies , 2008, The American Journal of Gastroenterology.

[36]  M. Vieth,et al.  Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett’s oesophagus , 2008, Gut.

[37]  L. Murray,et al.  The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. , 2008, American journal of epidemiology.

[38]  J. Blazeby,et al.  The Role of Health-Related Quality of Life Outcomes in Clinical Decision Making in Surgery for Esophageal Cancer: A Systematic Review , 2008, Annals of Surgical Oncology.

[39]  I. Cecconello,et al.  Barrett’s Esophagus (BE) and Carcinoma in the Esophageal Stump (ES) After Esophagectomy with Gastric Pull-Up in Achalasia Patients: A Study Based on 10 Years Follow-Up , 2008, Annals of Surgical Oncology.

[40]  Kenneth J. Chang,et al.  Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. , 2008, Gastrointestinal endoscopy.

[41]  W. Curvers,et al.  Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports , 2008, European journal of gastroenterology & hepatology.

[42]  Michael B Wallace,et al.  Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. , 2008, Gastroenterology.

[43]  R. Goyal,et al.  Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma , 2008, BMC clinical pathology.

[44]  L. Gossner,et al.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus , 2008, Gut.

[45]  J. G. de Groot,et al.  Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens , 2008, Genes, chromosomes & cancer.

[46]  M. Stolte,et al.  Adenocarcinoma developing in de novo Barrett's mucosa in the remnant esophagus after esophagectomy: clinical and molecular assessment. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[47]  M. Essink‐bot,et al.  Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. , 2008, International journal of radiation oncology, biology, physics.

[48]  Cheng-Fu Xu,et al.  A Systematic Review and Meta-Analysis of the Treatment for Barrett’s Esophagus , 2008, Digestive Diseases and Sciences.

[49]  G. Block,et al.  Dietary patterns and the risk of Barrett's esophagus. , 2008, American journal of epidemiology.

[50]  D. Low,et al.  Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. , 2008, Gastrointestinal endoscopy.

[51]  L. McMahon,et al.  Influence of Malpractice History on the Practice of Screening and Surveillance for Barrett's Esophagus , 2008, The American Journal of Gastroenterology.

[52]  M. Mazumdar,et al.  Multifocal Neoplasia and Nodal Metastases in T1 Esophageal Carcinoma: Implications for Endoscopic Treatment , 2008, Annals of surgery.

[53]  Fernando Ramos,et al.  A Randomized Comparison of Methylene Blue-Directed Biopsy Versus Conventional Four-Quadrant Biopsy for the Detection of Intestinal Metaplasia and Dysplasia in Patients With Long-Segment Barrett's Esophagus , 2008, The American Journal of Gastroenterology.

[54]  Thomas Rabenstein,et al.  Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus. , 2008, Gastroenterology.

[55]  H. El‐Serag,et al.  Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. , 2008, Gastrointestinal endoscopy.

[56]  V. Konda,et al.  Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[57]  J. Reguła,et al.  Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett’s esophagus , 2008, Journal of Molecular Medicine.

[58]  T. Jang,et al.  Sulindac Prevents Esophageal Adenocarcinomas Induced by Gastroduodenal Reflux in Rats , 2007, Yonsei medical journal.

[59]  P. Moayyedi,et al.  Mortality rates in patients with Barrett’s oesophagus , 2007, Alimentary pharmacology & therapeutics.

[60]  K. Abrams,et al.  Meta analysis: cancer risk in Barrett’s oesophagus , 2007, Alimentary pharmacology & therapeutics.

[61]  C. Prinz,et al.  High-resolution miniprobe-based confocal microscopy in combination with video mosaicing (with video). , 2007, Gastrointestinal endoscopy.

[62]  Kenneth K Wang,et al.  Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett's Esophagus , 2007, The American Journal of Gastroenterology.

[63]  Alexander Meining,et al.  In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[64]  D. Alderson,et al.  Quality of life during potentially curative treatment for locally advanced oesophageal cancer , 2007, The British journal of surgery.

[65]  Kenneth K Wang,et al.  Endoscopic tri-modal imaging for detection of early neoplasia in Barrett’s oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system , 2007, Gut.

[66]  J. Peters,et al.  Esophagectomy for High Grade Dysplasia is Safe, Curative, and Results in Good Alimentary Outcome , 2007, Journal of Gastrointestinal Surgery.

[67]  D. Forman,et al.  Risk of Mortality and Cancer Incidence in Barrett's Esophagus , 2007, Cancer Epidemiology Biomarkers & Prevention.

[68]  J. Hagen,et al.  Vagal-Sparing Esophagectomy: The Ideal Operation for Intramucosal Adenocarcinoma and Barrett with High-Grade Dysplasia , 2007, Annals of surgery.

[69]  R. Fitzgerald,et al.  Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. , 2007, Gastroenterology.

[70]  P. Parrilla,et al.  Tratamiento quirúrgico de la displasia de alto grado en el esófago de Barrett , 2007 .

[71]  P. Parrilla,et al.  [Surgical treatment of high-grade dysplasia in Barrett's esophagus]. , 2007, Cirugia espanola.

[72]  B. Overholt,et al.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.

[73]  C. Lightdale,et al.  Long-term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma , 2007, Endoscopy.

[74]  M. Bronner,et al.  Central adiposity and risk of Barrett's esophagus. , 2007, Gastroenterology.

[75]  D. Alderson,et al.  Health‐related quality of life among patients cured by surgery for esophageal cancer , 2007, Cancer.

[76]  J. Hunter,et al.  The Effect of Antireflux Surgery on Esophageal Carcinogenesis in Patients With Barrett Esophagus: A Systematic Review , 2007, Annals of surgery.

[77]  O. Pech,et al.  Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett’s esophagus , 2007, Endoscopy.

[78]  Prateek Sharma,et al.  Endoscopic surface imaging of Barrett's Esophagus: an optimistic view. , 2007, Gastroenterology.

[79]  G. Block,et al.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus. , 2007, Gastroenterology.

[80]  R. Cestari,et al.  Fluorescence in situ hybridization to evaluate dysplasia in Barrett's esophagus: a pilot study. , 2007, Cancer letters.

[81]  H. Pohl,et al.  Evaluation of endocytoscopy in the surveillance of patients with Barrett's esophagus. , 2007, Endoscopy.

[82]  Kenneth K Wang,et al.  Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population , 2007, Cancer.

[83]  A. Shar,et al.  Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. , 2007, Journal of the National Cancer Institute.

[84]  Patricia L. Blount,et al.  Extent of Low-Grade Dysplasia Is a Risk Factor for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus , 2007, The American Journal of Gastroenterology.

[85]  C. Lopes,et al.  Circumferential endoscopic resection of Barrett’s esophagus with high-grade dysplasia or early adenocarcinoma , 2007, Surgical Endoscopy.

[86]  Kamran Ayub,et al.  NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma , 2007, PLoS medicine.

[87]  Bergein F Overholt,et al.  Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. , 2007, Gastrointestinal endoscopy.

[88]  M. Scheurlen,et al.  High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation , 2007, Scandinavian journal of gastroenterology.

[89]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[90]  R. Odze,et al.  Diagnosis and grading of dysplasia in Barrett’s oesophagus , 2006, Journal of Clinical Pathology.

[91]  R. Sampliner,et al.  A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results , 2006, Gut.

[92]  M. Stolte,et al.  Ablation of Nonneoplastic Barrett's Mucosa Using Argon Plasma Coagulation with Concomitant Esomeprazole Therapy (APBANEX): A Prospective Multicenter Evaluation , 2006, The American Journal of Gastroenterology.

[93]  S. Spechler,et al.  High-Frequency Probe Ultrasonography Has Limited Accuracy for Detecting Invasive Adenocarcinoma in Patients with Barrett's Esophagus and High-Grade Dysplasia or Intramucosal Carcinoma: A Case Series , 2006, The American Journal of Gastroenterology.

[94]  P. Fockens,et al.  Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. , 2006, Gastrointestinal endoscopy.

[95]  J. Hagen,et al.  Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. , 2006, Journal of the American College of Surgeons.

[96]  Paul Fockens,et al.  Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[97]  A. Axon,et al.  Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[98]  L. Laine,et al.  Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. , 2006, The American journal of medicine.

[99]  J. Dent,et al.  The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus , 2006, The American Journal of Gastroenterology.

[100]  P. Fockens,et al.  Stepwise Radical Endoscopic Resection Is Effective for Complete Removal of Barrett's Esophagus with Early Neoplasia: A Prospective Study , 2006, The American Journal of Gastroenterology.

[101]  R. Odze,et al.  AMACR Immunostaining is Useful in Detecting Dysplastic Epithelium in Barrett's Esophagus, Ulcerative Colitis, and Crohn's Disease , 2006, The American journal of surgical pathology.

[102]  J. Lagergren,et al.  Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK , 2006, Gut.

[103]  G. Mills,et al.  Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward , 2006, Clinical Cancer Research.

[104]  D. Low,et al.  Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. , 2006, Archives of surgery.

[105]  K. Yao,et al.  Magnification endoscopy outlines the microvascular architecture and extent of Barrett's intramucosal carcinoma prior to endoscopic resection. , 2006, Gastrointestinal endoscopy.

[106]  N. Soehendra,et al.  Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video). , 2006, Gastrointestinal endoscopy.

[107]  R. Sampliner,et al.  Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[108]  D. Faigel,et al.  ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. , 2006, Gastrointestinal endoscopy.

[109]  R. Playford.  New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus , 2006, Gut.

[110]  C. Pellegrini,et al.  Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for barrett’s esophagus , 2006, Journal of Gastrointestinal Surgery.

[111]  C. Maley,et al.  Genetic Mechanisms of TP53 Loss of Heterozygosity in Barrett's Esophagus: Implications for Biomarker Validation , 2006, Cancer Epidemiology Biomarkers & Prevention.

[112]  B. Cooper,et al.  Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence , 2006, Alimentary pharmacology & therapeutics.

[113]  Michael Vieth,et al.  Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.

[114]  Carissa A. Sanchez,et al.  Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. , 2005, The Lancet. Oncology.

[115]  M. Solaymani-Dodaran,et al.  Mortality Associated with Barrett's Esophagus and Gastroesophageal Reflux Disease Diagnoses—A Population-Based Cohort Study , 2005, The American Journal of Gastroenterology.

[116]  J. Horwhat,et al.  Cryoablation of Barrett's esophagus: a pilot study. , 2005, Gastrointestinal endoscopy.

[117]  R. Cestari,et al.  Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. , 2005, World journal of gastroenterology.

[118]  A. Polglase,et al.  A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and the lower-GI tract. , 2005, Gastrointestinal endoscopy.

[119]  V. Sujendran,et al.  Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[120]  J. Connor,et al.  Barrett's esophagus in women: demographic features and progression to high-grade dysplasia and cancer. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[121]  D. Gotley,et al.  Interactions among Smoking, Obesity, and Symptoms of Acid Reflux in Barrett's Esophagus , 2005, Cancer Epidemiology Biomarkers & Prevention.

[122]  H. El‐Serag,et al.  Abdominal Obesity and the Risk of Barrett's Esophagus , 2005, The American Journal of Gastroenterology.

[123]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[124]  M. Feith,et al.  Early Esophageal Cancer: Pattern of Lymphatic Spread and Prognostic Factors for Long-Term Survival After Surgical Resection , 2005, Annals of surgery.

[125]  P. Fockens,et al.  High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. , 2005, Endoscopy.

[126]  C. Nwokolo,et al.  Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival , 2005, European journal of gastroenterology & hepatology.

[127]  L. Gossner,et al.  Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. , 2005, Gastrointestinal endoscopy.

[128]  R. Willén,et al.  Barrett Esophagus: Risk Factors for Progression to Dysplasia and Adenocarcinoma , 2005, Annals of surgery.

[129]  Govind Bhagat,et al.  EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[130]  R. Langer,et al.  Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. , 2005, Cancer research.

[131]  M. Pepe,et al.  Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk , 2005, Oncogene.

[132]  Paul Fockens,et al.  Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[133]  Paul Fockens,et al.  A randomized crossover study comparing light-induced fluorescence endoscopy with standard videoendoscopy for the detection of early neoplasia in Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[134]  Peter J. Richardson,et al.  Fundoplication and the Risk of Esophageal Cancer in Gastroesophageal Reflux Disease: A Veterans Affairs Cohort Study , 2005, The American Journal of Gastroenterology.

[135]  A. Bansal,et al.  The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[136]  R. Kiesslich,et al.  In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[137]  B. Edil,et al.  Surgical treatment of esophageal high-grade dysplasia. , 2005, The Annals of thoracic surgery.

[138]  S. Spechler,et al.  Dysplasia in Barrett's Esophagus: Limitations of Current Management Strategies , 2005, The American Journal of Gastroenterology.

[139]  N. Shaheen,et al.  Effect of a New Diagnosis of Barrett's Esophagus on Insurance Status , 2005, The American Journal of Gastroenterology.

[140]  Prateek Sharma,et al.  Magnification endoscopy. , 2005, Gastrointestinal endoscopy.

[141]  M. Vieth,et al.  Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation. , 2005, World journal of gastroenterology.

[142]  A. Ippoliti,et al.  Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[143]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[144]  K. Ragunath,et al.  Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: A randomized prospective trial assessing efficacy and cost-effectiveness , 2005, Scandinavian journal of gastroenterology.

[145]  C J Stoddard,et al.  Endoscopic ablation of Barrett's oesophagus: a randomized‐controlled trial of photodynamic therapy vs. argon plasma coagulation , 2004, Alimentary pharmacology & therapeutics.

[146]  M. Sprangers,et al.  Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[147]  A. Bhattacharyya,et al.  Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus , 2004, American Journal of Gastroenterology.

[148]  Prateek Sharma.  Low-grade dysplasia in Barrett's esophagus. , 2004, Gastroenterology.

[149]  T. Miyashita,et al.  A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats. , 2004, Carcinogenesis.

[150]  P. Schoenfeld,et al.  Profile of GERD in the Adult Population of a North East Urban Community , 2004, Journal of clinical gastroenterology.

[151]  G. Triadafilopoulos,et al.  Oesophageal and gastric pH profiles in patients with gastro‐oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors , 2004, Alimentary pharmacology & therapeutics.

[152]  G. Monges,et al.  Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. , 2004, Endoscopy.

[153]  J. Johansson,et al.  Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features. , 2004, Surgery.

[154]  A. Polglase,et al.  Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. , 2004, Gastroenterology.

[155]  Herbert C Wolfsen,et al.  Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy , 2004, BMC gastroenterology.

[156]  H. Sue-Ling,et al.  Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer , 2004, The British journal of surgery.

[157]  Janusz Jankowski,et al.  A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. , 2004, Gastroenterology.

[158]  Y. Kumagai,et al.  Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system. , 2004, Endoscopy.

[159]  Xin Qi,et al.  Computer-aided diagnosis of dysplasia in Barrett's esophagus using endoscopic optical coherence tomography. , 2006, Journal of biomedical optics.

[160]  Masahiro Yamaguchi,et al.  Appearance of enhanced tissue features in narrow-band endoscopic imaging. , 2004, Journal of biomedical optics.

[161]  J. Goldblum,et al.  Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens , 2004, Modern Pathology.

[162]  B. Shadbolt,et al.  Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus , 2004, The Medical journal of Australia.

[163]  J. O'riordan,et al.  Factors Influencing The Development of Barrett's Epithelium in The Esophageal Remnant Postesophagectomy , 2004, American Journal of Gastroenterology.

[164]  S. Spechler,et al.  Intestinal metaplasia at the gastroesophageal junction. , 2004, Gastroenterology.

[165]  R. Kiesslich,et al.  Inter- and Intra-Observer Variability of Magnification Chromoendoscopy for Detecting Specialized Intestinal Metaplasia at the Gastroesophageal Junction , 2004, Endoscopy.

[166]  O. Cummings,et al.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. , 2003, Gastroenterology.

[167]  N. Shaheen,et al.  Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis , 2003, American Journal of Gastroenterology.

[168]  D. Franchimont,et al.  Newly Developed Barrett’s Esophagus after Subtotal Esophagectomy , 2003, Endoscopy.

[169]  G. Triadafilopoulos,et al.  Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[170]  J. Wayman,et al.  Human model of duodenogastro‐oesophageal reflux in the development of Barrett's metaplasia , 2003, The British journal of surgery.

[171]  M. Feith,et al.  Pattern of Lymphatic Spread of Barrett’s Cancer , 2003, World Journal of Surgery.

[172]  J. Olliver,et al.  Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus , 2003, The Lancet.

[173]  Masoud Panjehpour,et al.  Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. , 2003, Gastrointestinal endoscopy.

[174]  A. Gavin,et al.  Mortality in Barrett’s oesophagus: results from a population based study , 2003, Gut.

[175]  Kenneth K Wang,et al.  Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[176]  K. Hemming,et al.  Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[177]  C. Maynard,et al.  A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD. , 2003, Gastrointestinal endoscopy.

[178]  N. Soehendra,et al.  Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. , 2003, Gastrointestinal endoscopy.

[179]  T. Stephenson,et al.  Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. , 2003, Endoscopy.

[180]  N. Soehendra,et al.  Endoscopic mucosal resection. , 2003, Gastrointestinal endoscopy.

[181]  M. Edelweiss,et al.  Does methylene blue detect intestinal metaplasia in Barrett's esophagus? , 2003, Gastrointestinal endoscopy.

[182]  R. Cade,et al.  Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus , 2003, ANZ journal of surgery.

[183]  P. Familiari,et al.  Endoscopic treatment of Barrett's epithelium with Argon Plasma Coagulation. Long-term follow-up. , 2003, Minerva gastroenterologica e dietologica.

[184]  R. Heitmiller.  Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia , 2003, Langenbeck's Archives of Surgery.

[185]  C. Yeo,et al.  Barrett’s esophagus with high grade dysplasia: Surgical results and long-term outcome— An update , 2003, Journal of Gastrointestinal Surgery.

[186]  John A. Cowan,et al.  Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? , 2003, The Annals of thoracic surgery.

[187]  D Nolte,et al.  Time gated fluorescence spectroscopy in Barrett’s oesophagus , 2003, Gut.

[188]  A. Bhattacharyya,et al.  Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus , 2003, Gut.

[189]  D. W. Choi,et al.  Endoscopically Observed Lower Esophageal Capillary Patterns , 2002, The Korean journal of internal medicine.

[190]  J. Luketich,et al.  Minimally Invasive Esophagectomy in the Elderly , 2002, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

[191]  S. Spechler,et al.  Racial differences in the frequency of symptoms and complications of gastro‐oesophageal reflux disease , 2002, Alimentary pharmacology & therapeutics.

[192]  J. Birkmeyer,et al.  Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.

[193]  A. Chak,et al.  Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia , 2002, Cancer.

[194]  G. Triadafilopoulos,et al.  Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus. , 2002, Gastroenterology.

[195]  K. Chu,et al.  Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. , 2002, The New England journal of medicine.

[196]  P. Pairolero,et al.  High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. , 2002, The Annals of thoracic surgery.

[197]  F. Bazzoli,et al.  Endoscopic surveillance in Barrett's esophagus. , 2002, Minerva gastroenterologica e dietologica.

[198]  Kenneth K Wang,et al.  Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. , 2002, Gastroenterology.

[199]  Kenneth K Wang,et al.  The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. , 2002, Journal of the National Cancer Institute.

[200]  J. Johansson,et al.  Metaplastic Columnar Mucosa in the Cervical Esophagus After Esophagectomy , 2002, Annals of surgery.

[201]  Noel S Weiss,et al.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study. , 2002, Gastroenterology.

[202]  A. Sonnenberg,et al.  Hiatal Hernia and Acid Reflux Frequency Predict Presence and Length of Barrett's Esophagus , 2002, Digestive Diseases and Sciences.

[203]  J. Collard.  High-grade dysplasia in Barrett's esophagus. The case for esophagectomy. , 2002, Chest surgery clinics of North America.

[204]  S. Spechler,et al.  Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. , 2002, Gastroenterology.

[205]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[206]  Nina Singh,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[207]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[208]  W. Chow,et al.  Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. , 2001, Gastroenterology.

[209]  Z. Halpern,et al.  Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus , 2001, Oncogene.

[210]  J. Cameron,et al.  Esophagectomy for adenocarcinoma in patients 45 years of age and younger , 2001, Journal of Gastrointestinal Surgery.

[211]  J. Peters,et al.  Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. , 2001, Archives of surgery.

[212]  D. Provenzale,et al.  Clinical and Demographic Predictors of Barrett's Esophagus Among Patients With Gastroesophageal Reflux Disease: A Multivariable Analysis in Veterans , 2001, Journal of clinical gastroenterology.

[213]  M. Gammon,et al.  Nutrient intake and risk of subtypes of esophageal and gastric cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[214]  R. Fitzgerald,et al.  Rigorous Surveillance Protocol Increases Detection of Curable Cancers Associated with Barrett's Esophagus , 2001, Digestive Diseases and Sciences.

[215]  M. Mayo,et al.  Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus. , 2001, Gastrointestinal endoscopy.

[216]  P. Pronovost,et al.  Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland. , 2001, The Annals of thoracic surgery.

[217]  V. Eckardt,et al.  Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. , 2001, The American journal of medicine.

[218]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[219]  K. Badizadegan,et al.  Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. , 2001, Gastroenterology.

[220]  R. Sampliner,et al.  Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. , 2001, JAMA.

[221]  E. Furth,et al.  Short-segment Barrett's esophagus: findings on double-contrast esophagography in 20 patients. , 2001, AJR. American journal of roentgenology.

[222]  D. Faigel,et al.  Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. , 2001, Gastrointestinal endoscopy.

[223]  M. Sivak,et al.  Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. , 2001, Endoscopy.

[224]  C. Buskens,et al.  Hospital volume and hospital mortality for esophagectomy , 2001, Cancer.

[225]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[226]  E. Montgomery,et al.  Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. , 2001, Human pathology.

[227]  Carissa A. Sanchez,et al.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression , 2001, American Journal of Gastroenterology.

[228]  F. Chan,et al.  Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. , 2001, The New England journal of medicine.

[229]  Bipan Chand,et al.  High-resolution and high-magnification endoscopes. , 2000, Gastrointestinal endoscopy.

[230]  D. Faigel,et al.  High resolution and high-magnification endoscopy: September 2000. , 2000, Gastrointestinal endoscopy.

[231]  M. Sprangers,et al.  Quality of life in long‐term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma , 2000, The British journal of surgery.

[232]  D. Bowrey,et al.  Barrett's esophagus: a surgical disease? , 2000, The American journal of gastroenterology.

[233]  D. Beer,et al.  Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. , 2000, Cancer research.

[234]  M Fitzmaurice,et al.  Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy. , 2000, Gastroenterology.

[235]  A. Ruol,et al.  Oesophageal resection for high‐grade dysplasia in Barrett's oesophagus , 2000, The British journal of surgery.

[236]  R. Sandler,et al.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.

[237]  D. Beer,et al.  Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression. , 2000, Neoplasia.

[238]  Gary Longton,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.

[239]  J. Donovan,et al.  A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma , 2000, Cancer.

[240]  J. Stanford,et al.  Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer , 2000, Cancer Causes & Control.

[241]  M. Guelrud,et al.  Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[242]  C. Compton,et al.  High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography. , 2000, Gastrointestinal endoscopy.

[243]  T. Demeester,et al.  Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. , 2000, Annals of surgery.

[244]  M. Omary,et al.  Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. , 2000, Gastroenterology.

[245]  P. Schauer,et al.  Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. , 2000, Surgery.

[246]  P. S. Rana,et al.  Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance. , 2000, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[247]  U. Ladabaum,et al.  Barrett's Esophagus with High-Grade Dysplasia , 1999 .

[248]  A. Spinelli,et al.  [Complications of Barrett's esophagus: indications for esophageal resection with special reference to high-grade dysplasia]. , 1999, Minerva chirurgica.

[249]  F. Sinicrope,et al.  Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. , 1999, Cancer research.

[250]  N. Brandalise,et al.  Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[251]  R. Fitzgerald,et al.  Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. , 1999, Gastroenterology.

[252]  Dawn Provenzale,et al.  Does this patient have Barrett's esophagus? the utility of predicting Barrett's esophagus at the index endoscopy , 1999, American Journal of Gastroenterology.

[253]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[254]  R. Doherty.  Long term follow up , 1999, BMJ.

[255]  C. Begg,et al.  Impact of hospital volume on operative mortality for major cancer surgery. , 1998, JAMA.

[256]  G. Tytgat,et al.  Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma , 1998, Gut.

[257]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[258]  P. Schauer,et al.  Minimally Invasive Approach to Esophagectomy , 1998, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

[259]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[260]  R. Sampliner,et al.  Short segment Barrett's esophagus—the need for standardization of the definition and of endoscopic criteria , 1998, American Journal of Gastroenterology.

[261]  J. Izatt,et al.  High-resolution cross-sectional imaging of the gastrointestinal tract using optical coherence tomography: preliminary results. , 1998, Gastrointestinal endoscopy.

[262]  M. Guelrud,et al.  Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy. , 1998, Gastrointestinal endoscopy.

[263]  L. Gossner,et al.  Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. , 1998, Gastroenterology.

[264]  A. Schned,et al.  The Development of Dysplasia and Adenocarcinoma During Endoscopic Surveillance of Barrett's Esophagus , 1998, American Journal of Gastroenterology.

[265]  L. Way,et al.  A hospital’s annual rate of esophagectomy influences the operative mortality rate , 1998, Journal of Gastrointestinal Surgery.

[266]  J. Goldblum,et al.  Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. , 1998, The Annals of thoracic surgery.

[267]  E. Kuipers,et al.  Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus. , 1997, Scandinavian journal of gastroenterology.

[268]  A. Hölscher,et al.  Early adenocarcinoma in Barrett's oesophagus , 1997, The British journal of surgery.

[269]  M. Helfand,et al.  Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.

[270]  P. Chandrasoma.  Pathophysiology of Barrett's esophagus. , 1997, Seminars in thoracic and cardiovascular surgery.

[271]  A. Mclarty,et al.  Esophageal resection for cancer of the esophagus: long-term function and quality of life. , 1997, The Annals of thoracic surgery.

[272]  A R Zinsmeister,et al.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. , 1997, Gastroenterology.

[273]  M. Omary,et al.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. , 1996, The Journal of clinical investigation.

[274]  R. Heitmiller,et al.  Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. , 1996, Annals of surgery.

[275]  J. Richardson,et al.  The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. , 1996, Annals of surgery.

[276]  J. Fraumeni,et al.  The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. , 1995, JAMA.

[277]  W. Hop,et al.  Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. , 1995, Gut.

[278]  D. Alberts,et al.  Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. , 1995, Cancer research.

[279]  J. Williams,et al.  Gastrointestinal Quality of Life Index: Development, validation and application of a new instrument , 1995, The British journal of surgery.

[280]  J. Peters,et al.  Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.

[281]  V. Rusch,et al.  The management of high grade dysplasia and early cancer in Barrett's esophagus , 1994, Cancer.

[282]  D. Katzka,et al.  Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. , 1994, The American journal of gastroenterology.

[283]  T. Lerut,et al.  Surgical treatment of Barrett's carcinoma , 1994 .

[284]  P. D. De Leyn,et al.  Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. , 1994, The Journal of thoracic and cardiovascular surgery.

[285]  M. Catalano,et al.  Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia. , 1994, Gastrointestinal endoscopy.

[286]  T. Rice,et al.  Surgical management of high-grade dysplasia in Barrett's esophagus. , 1993, The American journal of gastroenterology.

[287]  F. Ellis,et al.  Endoscopic surveillance of Barrett's esophagus. Does it help? , 1993, The Journal of thoracic and cardiovascular surgery.

[288]  P. Pairolero,et al.  Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? , 1992, The Annals of thoracic surgery.

[289]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[290]  J. Mayberry,et al.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.

[291]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[292]  S. McClave,et al.  Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. , 1987, Gastrointestinal endoscopy.

[293]  P. Hayes,et al.  Normal venous circulation of the gastroesophageal junction. A route to understanding varices. , 1987, Gastroenterology.

[294]  R C Heading,et al.  Barrett's oesophagus. , 1987, British medical journal.

[295]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.

[296]  Paul Fockens,et al.  Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[297]  Prateek Sharma,et al.  Endoscopic eradication of Barrett's esophagus. , 2010, Gastrointestinal endoscopy.

[298]  D. R. Jones.  The effect of volume on esophageal cancer resections: What constitutes acceptable resection volumes for centers of excellence? , 2010 .

[299]  K. Behrns.  Endoscopic and Surgical Treatment of Mucosal (T1a) Esophageal Adenocarcinoma in Barrett's Esophagus , 2010 .

[300]  J. Jankowski,et al.  Chemoprevention of oesophageal cancer and the AspECT trial. , 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[301]  G. Darling,et al.  Health-related quality of life in esophageal cancer: effect of neoadjuvant chemoradiotherapy followed by surgical intervention. , 2009, The Journal of thoracic and cardiovascular surgery.

[302]  M. Vieth,et al.  Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. , 2009, Human pathology.

[303]  B. Overholt,et al.  Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. , 2009, Gastroenterology.

[304]  Á. Lanas,et al.  Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[305]  A. Neugut,et al.  Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[306]  E. Kuipers,et al.  Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus. , 2008, Cancer biomarkers : section A of Disease markers.

[307]  T. Hastie,et al.  Does cancer risk affect health-related quality of life in patients with Barrett's esophagus? , 2007, Gastrointestinal endoscopy.

[308]  Mari Mino-Kenudson,et al.  Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[309]  Az Amsterdam,et al.  High-resolution endoscopy plus chromoendoscopy or narrow- band imaging in Barrett's esophagus: A prospective randomized crossover study , 2006 .

[310]  D. Forman,et al.  Meta-Analysis A Systematic Review and Meta-Analysis of the Sex Ratio for Barrett’s Esophagus, Erosive Reflux Disease, and Nonerosive Reflux Disease , 2005 .

[311]  D. Provenzale,et al.  The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. , 2005, Gastroenterology.

[312]  K. Kerlikowske,et al.  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. , 2003, Gastroenterology.

[313]  J. Fléjou,et al.  High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins , 2002, Virchows Archiv.

[314]  B E Bouma,et al.  Diagnosis of specialized intestinal metaplasia by optical coherence tomography. , 2001, Gastroenterology.

[315]  D. Provenzale,et al.  Screening strategies in gastroesophageal reflux disease: early identification of esophageal carcinoma. , 2001, Advances in internal medicine.

[316]  Patricia L. Blount,et al.  Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables , 2001, American Journal of Gastroenterology.

[317]  Technology status evaluation report. High resolution and high-magnification endoscopy. , 2000, Gastrointestinal endoscopy.

[318]  Dawn Provenzale,et al.  Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk , 1999, American Journal of Gastroenterology.

[319]  I. Wiklund,et al.  Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). , 1998, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[320]  R. Sandler,et al.  The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.

[321]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[322]  P. Blount,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.

[323]  J. Hayward.  The lower end of the oesophagus. , 1961, Thorax.